(Q41332341)

29 September 2017

1 reference

title

ACE inhibitors and proteinuria (English)

1 reference

29 September 2017

R T Gansevoort

1

1 reference

29 September 2017

D de Zeeuw

series ordinal

2

1 reference

29 September 2017

P E de Jong

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

International Journal of Clinical Pharmacy

29 September 2017

published in

1 reference

29 September 2017

volume

18

1 reference

29 September 2017

issue

6

1 reference

29 September 2017

page(s)

204-210

1 reference

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

29 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00735961

DuP 753 is a specific antagonist for the angiotensin receptor.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00735961

Prognostic indicators in patients presenting with the nephrotic syndrome.

21 January 2018

1 reference

12 December 2020

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

12 December 2020

Nephrotic syndrome in patient on captopril

1 reference

12 December 2020

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

12 December 2020

Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure

1 reference

12 December 2020

Effects of different antihypertensive drugs on human diabetic proteinuria

1 reference

12 December 2020

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

12 December 2020

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.

1 reference

12 December 2020

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

12 December 2020

Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril

1 reference

12 December 2020

Membranous glomerulopathy in a patient on captopril

1 reference

12 December 2020

Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of action

1 reference

12 December 2020

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

1 reference

12 December 2020

Proteinuria during long-term captopril therapy

1 reference

12 December 2020

Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria

1 reference

12 December 2020

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

12 December 2020

Angiotensin II as a renal growth factor

1 reference

12 December 2020

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

12 December 2020

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

12 December 2020

Membranous Glomerulopathy and Nephrotic Syndrome After Captopril Therapy

1 reference

12 December 2020

Protein diet and nephrotic syndrome

1 reference

12 December 2020

Lipoprotein(a) in patients with proteinuria

1 reference

12 December 2020

Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure

1 reference

12 December 2020

Proteinuria as a prognostic factor during long term hypertensive care

1 reference

12 December 2020

The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP)

1 reference

12 December 2020

Increased renal plasma flow in long-term enalapril treatment of hypertension

1 reference

12 December 2020

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

12 December 2020

Serum-sickness-like syndrome with membranous glomerulopathy in patient on captopril

1 reference

12 December 2020

Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria

1 reference

12 December 2020

Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition

1 reference

12 December 2020

Effect of antihypertensive treatment on kidney function in diabetic nephropathy

1 reference

12 December 2020

Reduction in albuminuria predicts diminished progression in diabetic nephropathy.

1 reference

12 December 2020

The increased risk of coronary heart disease associated with nephrotic syndrome

1 reference

12 December 2020

Renal hemodynamic effects of a short-term high protein and low protein diet in patients with renal disease.

1 reference

12 December 2020

Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin

1 reference

12 December 2020

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

12 December 2020

Proteinuria and hypertension.

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome

1 reference

12 December 2020

Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake.

1 reference

12 December 2020

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

12 December 2020

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

12 December 2020

The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic Syndrome

1 reference

12 December 2020

Prognostic significance of microalbuminuria.

1 reference

12 December 2020

Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease

1 reference

12 December 2020

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

12 December 2020

Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome

1 reference

12 December 2020

Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome

1 reference

12 December 2020

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

12 December 2020

Treatment of the nephrotic syndrome with indomethacin.

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Acute effects of captopril and ibuprofen on proteinuria in patients with nephrosis

1 reference

12 December 2020

Does captopril cause renal damage in hypertensive patients? Report from the Captopril Collaborative Study Group

1 reference

12 December 2020

Side-effects of captopril

1 reference

12 December 2020

Progressive renal disease: role of race and antihypertensive medications

1 reference

12 December 2020

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

12 December 2020

Hydrolysis of bradykinin by angiotensin-converting enzyme

1 reference

12 December 2020

Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients

1 reference

12 December 2020

Bradykinin-mediated effects of ACE inhibition.

1 reference

12 December 2020

The emerging concept of vascular remodeling

1 reference

12 December 2020

Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome

1 reference

12 December 2020

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

12 December 2020

The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults

1 reference

12 December 2020

The prognostic significance of proteinuria: the Framingham study

1 reference

12 December 2020

The treatment of hypoalbuminemia in the critically ill patient.

1 reference

12 December 2020

Short-term effects of calcium antagonists on renal haemodynamics in patients with chronic renal failure

1 reference

12 December 2020

Captopril treatment of hypertension and renal failure in systemic lupus erythematosus

1 reference

12 December 2020

Kinin contribution to renal vasodilator effect of captopril in rabbit

1 reference

12 December 2020

Glomerular and hormonal responses to dietary protein intake in human renal disease

1 reference

12 December 2020

Hyperlipidemia in the nephrotic syndrome

1 reference

12 December 2020

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

12 December 2020

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease

1 reference

12 December 2020

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy

1 reference

12 December 2020

Progression of renal insufficiency: role of blood pressure

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00735961

1 reference

29 September 2017

1 reference